Entera Bio (ENTX) Net Equity Issued and Repurchased (2021 - 2025)
Entera Bio's (ENTX) quarterly Net Equity Issued and Repurchased came in at $71000.0 in Q3 2025, down 98.85% on a QoQ basis from $6.2 million in Q1 2025.
Entera Bio (ENTX) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Entera Bio (ENTX) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $71000.0 in Q3 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $71000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $71000.0 (down 99.3% YoY) and the FY2025 annual result came in at $6.3 million, up 57.93% from the prior year.
- Net Equity Issued and Repurchased fell to $71000.0 in Q3 2025, from $6.2 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $9.9 million in Q1 2021 to a low of $71000.0 in Q3 2025.
- A 3-year average of $4.6 million and a median of $3.3 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Entera Bio | 161.44 Mn | 150.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 71,000.00 |
| Sep 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 6.18 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Jun 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 620,000.00 |
| Sep 30, 2021 | 2.46 Mn |
| Sep 30, 2021 | 2.46 Mn |
| Jun 30, 2021 | 9.48 Mn |
| Jun 30, 2021 | 9.48 Mn |
| Mar 31, 2021 | 9.86 Mn |
| Mar 31, 2021 | 9.86 Mn |